<DOC>
	<DOCNO>NCT00490919</DOCNO>
	<brief_summary>The objective study determine analgesic efficacy safety Buprenorphine Transdermal System ( BTDS ) 10 20 compare placebo opioid-na√Øve subject moderate severe chronic low back pain . The double-blind treatment intervention duration 12 week , time supplemental analgesic medication ( immediate-release oxycodone first 6 day post-randomization acetaminophen ibuprofen remainder double-blind phase ) provide subject addition study drug .</brief_summary>
	<brief_title>Buprenorphine Transdermal System ( BTDS ) Subjects With Moderate Severe Chronic Low Back Pain</brief_title>
	<detailed_description>Buprenorphine synthetic opioid analgesic 25 year international clinical experience indicate safe effective variety therapeutic setting relief moderate severe pain . BTDS transdermal system formulation design deliver consistent steady dose buprenorphine 7-day period limit blood concentration fluctuation .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Subjects moderate severe chronic low back pain ( lasting several hour daily ) predominant pain condition least 3 month prior screen , Subjects treat within 14 day prior screen nonopioid therapy , therapy include opioids dose &lt; 5 mg oxycodone ( equivalent ) per day , Subjects whose low back pain adequately control nonopioid analgesic medication Investigator feel appropriate candidate aroundtheclock opioid therapy Subjects surgical procedure direct towards source back pain within 6 month screen plan study conduct period , Subjects allergic buprenorphine history allergy opioids , Subjects allergies contraindication transdermal delivery system patch adhesive . Other protocolspecific inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Chronic pain</keyword>
	<keyword>opioid</keyword>
	<keyword>transdermal</keyword>
	<keyword>Moderate severe chronic low back pain</keyword>
</DOC>